Enhanced Post-traumatic Headache-like Behaviors and Diminished Contribution of Peripheral CGRP in Female Rats Following a Mild Closed Head Injury
Overview
Affiliations
Introduction: Females are thought to have increased risk of developing post-traumatic headache following a traumatic head injury or concussion. However, the processes underlying this susceptibility remain unclear. We previously demonstrated the development of post-traumatic headache-like pain behaviors in a male rat model of mild closed head injury, along with the ability of sumatriptan and an anti-calcitonin-gene-related peptide monoclonal antibody to ameliorate these behaviors. Here, we conducted a follow-up study to explore the development of post-traumatic headache-like behaviors and the effectiveness of these headache therapies in females subjected to the same head trauma protocol.
Methods: Adult female Sprague Dawley rats were subjected to a mild closed head injury using a weight-drop device (n = 126), or to a sham procedure (n = 28). Characterization of headache and pain related behaviors included assessment of changes in cutaneous cephalic and extracephalic tactile pain sensitivity, using von Frey monofilaments. Sensitivity to headache/migraine triggers was tested by examining the effect of intraperitoneal administration of a low dose of glyceryl trinitrate (100 µg/kg). Treatments included acute systemic administration of sumatriptan (1 mg/kg) and repeated systemic administration of a mouse anti-calcitonin gene-related peptide monoclonal antibody (30 mg/kg). Serum levels of calcitonin gene-related peptide were measured at baseline and at various time points post head injury in new cohorts of females (n = 38) and males (n = 36).
Results: Female rats subjected to a mild closed head injury developed cutaneous mechanical hyperalgesia, which was limited to the cephalic region and was resolved 4 weeks later. Cephalic pain hypersensitivity was ameliorated by treatment with sumatriptan but was resistant to an early and prolonged treatment with the anti-calcitonin gene-related peptide monoclonal antibody. Following the resolution of the head injury-evoked cephalic hypersensitivity, administration of glyceryl trinitrate produced a renewed and pronounced cephalic and extracephalic pain hypersensitivity that was inhibited by sumatriptan, but only partially by the anti-calcitonin gene-related peptide treatment. Calcitonin gene-related peptide serum levels were elevated in females but not in males at 7 days post head injury.
Conclusions: Development of post-traumatic headache-like pain behaviors following a mild closed head injury, and responsiveness to treatment in rats is sexually dimorphic. When compared to the data obtained from male rats in the previous study, female rats display a prolonged state of cephalic hyperalgesia, increased responsiveness to a headache trigger, and a poorer effectiveness of an early and prolonged anti-calcitonin gene-related peptide treatment. The increased risk of females to develop post-traumatic headache may be linked to enhanced responsiveness of peripheral and/or central pain pathways and a mechanism independent of peripheral calcitonin gene-related peptide signaling.
Cortical astrocyte activation triggers meningeal nociception and migraine-like pain.
Bree D, Zhao J, Stratton J, Levy D bioRxiv. 2025; .
PMID: 39975142 PMC: 11839082. DOI: 10.1101/2025.02.08.637109.
Eggertsen P, Palmfeldt J, Schytz H, Hay D, Olsen R, Nielsen J J Neurol. 2024; 271(5):2458-2472.
PMID: 38231270 PMC: 11055722. DOI: 10.1007/s00415-024-12181-y.
Rudolph M, Kopruszinski C, Wu C, Navratilova E, Schwedt T, Dodick D Cephalalgia. 2023; 43(11):3331024231217469.
PMID: 38016977 PMC: 11149587. DOI: 10.1177/03331024231217469.
Christensen J, MacPherson N, Li C, Yamakawa G, Mychasiuk R J Headache Pain. 2023; 24(1):72.
PMID: 37316796 PMC: 10268396. DOI: 10.1186/s10194-023-01608-y.
Effect of Voluntary Exercise on Endogenous Pain Control Systems and Post-traumatic Headache in Mice.
Bharadwaj V, Sahbaie P, Shi X, Irvine K, Yeomans D, Clark J J Pain. 2023; 24(10):1859-1874.
PMID: 37271350 PMC: 11806938. DOI: 10.1016/j.jpain.2023.05.015.